Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis (ATOM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by University of Oxford.
Recruitment status was  Recruiting
Mahidol University
Wellcome Trust
Information provided by:
University of Oxford Identifier:
First received: December 18, 2007
Last updated: June 3, 2008
Last verified: August 2007
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):